Approval · Notice of Compliance 7202 · 2005
KETEK: Notice of Compliance 7202
Issued June 22, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7202
- Date
- June 22, 2005
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to the approved community acquired pneumonia indication to include additional pathogens and revised treatment duration
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KETEK | Not yet assigned | — |
Medicinal ingredients
- TELITHROMYCIN 400 MG per TAB